NCT01906697

Brief Summary

The aim of this study is to evaluate the effect of middle turbinate Radio Frequency (RF) turbinoplasty with middle turbinate resection and medialization

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

July 19, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 24, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

July 24, 2013

Status Verified

July 1, 2013

Enrollment Period

2.3 years

First QC Date

July 19, 2013

Last Update Submit

July 23, 2013

Conditions

Outcome Measures

Primary Outcomes (3)

  • The Sino-Nasal Outcomes Test 22

    The Sino-Nasal Outcome Test-22 (SNOT-22) questionnaire is a disease-specific questionnaire involving 22 symptoms combining rhinologic issues with general health issues.

    three months after surgery

  • The Sino-Nasal Outcomes Test 22

    The Sino-Nasal Outcome Test-22 (SNOT-22) questionnaire is a disease-specific questionnaire involving 22 symptoms combining rhinologic issues with general health issues.

    6 months after surgery

  • The Sino-Nasal Outcomes Test 22

    The Sino-Nasal Outcome Test-22 (SNOT-22) questionnaire is a disease-specific questionnaire involving 22 symptoms combining rhinologic issues with general health issues.

    one year after surgery

Study Arms (3)

group B

ACTIVE COMPARATOR

middle turbinate resection

Procedure: middle turbinate resection

group C

ACTIVE COMPARATOR

middle turbinate medialization

Procedure: middle turbinate medialization

group A

ACTIVE COMPARATOR

middle turbinate Radio Frequency (RF) turbinoplasty

Procedure: middle turbinate Radio Frequency (RF) turbinoplasty

Interventions

middle turbinate Radio Frequency (RF) turbinoplasty

group A

middle turbinate resection

group B

middle turbinate medialization

group C

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patients with sinusitis who suffered from nasal polyposis which was resistant to maximal medical treatment (i.e. one puff of Fluticasone nasal spray twice daily plus amoxicillin clavulanic acid 625 mg tablet three times daily, for at least one month ).

You may not qualify if:

  • floppy' change of the middle turbinate in the end of surgery.
  • systemic disease (e.g. hypertension, Wegener's granulomatosis, cystic fibrosis or sarcoidosis),
  • immune suppression,
  • revision surgery,
  • counter-indications for any of the postoperative drug usage (e.g. diabetes or pregnancy), or
  • any type of septoplasty indications are excluded from this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tehran University of Medical Sciences

Tehran, Tehran Province, 94305, Iran

Location

MeSH Terms

Conditions

Nasal PolypsSinusitis

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsInfectionsParanasal Sinus Diseases

Study Officials

  • Babak Saedi, professor

    Tehran University of Medical Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 19, 2013

First Posted

July 24, 2013

Study Start

May 1, 2011

Primary Completion

September 1, 2013

Study Completion

October 1, 2013

Last Updated

July 24, 2013

Record last verified: 2013-07

Locations